sevoflurane + dexmedetomidine

Sevoflurane + dexmedetomidine is a combination of two pharmaceutical agents used in anesthesia. Sevoflurane is a volatile inhalational anesthetic that induces and maintains general anesthesia by altering neuronal excitability, primarily through effects on ion channels and gap junctions, leading to muscle relaxation and loss of consciousness. Dexmedetomidine is a highly selective alpha-2 adrenergic receptor agonist that provides sedation, anxiolysis, analgesia, and sympatholytic effects without significant respiratory depression. When combined, dexmedetomidine can reduce the required dose (minimal alveolar concentration) of sevoflurane for effective anesthesia or sedation. This combination has been shown to provide stable hemodynamics during surgery, reduce stress responses (such as during laryngeal mask airway placement), improve perioperative outcomes like controlled hypotension or reduced emergence agitation in pediatric patients, and may offer neuroprotective benefits by potentially mitigating some neurotoxic effects associated with higher doses of volatile anesthetics[1][3][5][6]. The combination is not marketed under a unique brand name but represents an off-label or protocol-driven use in clinical practice.